Charles River

$306.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.20 (+0.39%) Today

$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Charles River and other stocks, options, and ETFs commission-free!

About CRL

Charles River Laboratories International, Inc., also called Charles River, is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support.

CEO

James C. Foster

Employees

18,400

Headquarters

Wilmington, Massachusetts

Founded

1947

Market Cap

15.23B

Price-Earnings Ratio

42.40

Dividend Yield

—

Average Volume

354.64K

High Today

$306.22

Low Today

$300.73

Open Price

$304.94

Volume

238.17K

52 Week High

$307.44

52 Week Low

$133.57

Analyst Ratings

76%

of 17 ratings

Buy

76%

Hold

18%

Sell

CRL Earnings

$0.00

$0.80

$1.59

$2.39

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, Pre-Market